NCT02594410View on ClinicalTrials.gov

Zainidip in Renal Artery Stenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2014

Conditions
Hypertension
Interventions
DEVICE

stent

patients receiving renal artery stenting for renal artery atherosclerosis

DRUG

Aspirine

100mg Qd

DRUG

Clopidogrel

75mg Qd

DRUG

Lercanidipine

10-20mg Qd

Trial Locations (1)

Unknown

Fuwai Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY